Fully Human Antibody Targeting PD1 For Cancer Immunotherapy
US Application 62/346,694
Filed on 2016-06-07
Filed on 2016-06-07
ANTI-KRAS-G12D T Cell Receptors
US Application 62/369,883
Filed on 2016-08-02
Filed on 2016-08-02
Therapeutic Antitumor Combination Of A TLR4 Ligand With Other Treatments
US Application 62/355,134
Filed on 2016-06-27
Filed on 2016-06-27
New, More Stable Immunotoxin Variants With A Disulfide Bond Protecting The Furin Cleavage Site
US Application 62/323,668
Filed on 2016-04-16
Filed on 2016-04-16
Anti-KK-LC-1 T Cell Receptors
US Application 62/327,529
Filed on 2016-04-26
Filed on 2016-04-26
FLT3-Specific Chimeric Antigen Receptors and Methods Using Same
US Application 62/342,394
Filed on 2016-05-27
Filed on 2016-05-27
Human RPN2 Derived Peptides Useful For Treating Cancer
US Application 62/232,144
Filed on 2015-09-24
Filed on 2015-09-24
Extracellular Vesicles, Methods of Making Them, and Methods of Reducing Liver Uptake of Extracellular Vesicles
US Application 62/316,276
Filed on 2016-03-31
Filed on 2016-03-31
Variable New Antigen Receptor (VNAR) Antibodies and Antibody Conjugates Targeting Tumor and Viral Antigens
US Application 62/334,194
Filed on 2016-05-10
Filed on 2016-05-10
Use Of Heterodimeric IL-15 In Adoptive Cell Transfer
US Application 62/319,259
Filed on 2016-04-06
Filed on 2016-04-06